Top News
Survey: Most Hem/Oncs Don’t Have Time to Help Patients With Social Needs
Pepaxto Withdrawn from US Market Following OCEAN Trial Results
Acalabrutinib, Venetoclax, Obinutuzumab Shows Promise as Frontline Therapy for Chronic Lymphocytic Leukemia
Vismodegib Demonstrates Efficacy in Basal Cell Carcinoma
CDC: Booster Recommendations Expanded to All Authorized COVID-19 Vaccines
Nivolumab Prolongs PFS, OS in Relapsed Malignant Mesothelioma
MRD Assessment Can Guide Treatment Discontinuation in CLL/SLL
Assessing Priorities in End-of-Life Care for Children With Cancer
Diagnosis and Management of Differentiation Syndrome in Patients With Acute Myeloid Leukemia
ASA: Dexamethasone Use During Cancer Surgery May Reduce Mortality
More Than Half of COVID-19 Survivors Have Postacute Sequelae
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
PTSD in Cancer Patients: What Providers Need to Know
Experts outline risk factors for PTSD and explain how PTSD can affect cancer outcomes. -
HSCT After COVID-19 Appears Safe, but Most Patients Lose SARS-CoV-2 Antibodies
All patients achieved engraftment, and none developed complications associated with COVID-19. -
Equal Access to Care May Eliminate Racial Disparities in Lung Cancer Outcomes
One study suggested that modifiable factors could improve racial disparities in the stage at which lung cancer is diagnosed. -
Second Dose of COVID-19 Vaccine Not Enough for Some Patients With Cancer
About half of patients with impaired seroconversion after the first dose of a COVID-19 vaccine still had low antibody levels after the second dose. -
Pandemic-Related Delays in Cancer Surgery May Not Affect Short-Term Outcomes
There was no increase in unresectable disease, new metastatic disease, or 30-day mortality associated with increasing delays. -
Genomic Sequencing in Pediatric Cancer: For Every Patient at Every Relapse
More than one-third of tumors sequenced carried a high mutation burden. -
Breast, Prostate Cancer Common in Patients With COVID-19 and Cancer History
For patients hospitalized with COVID-19, prostate cancer was the most common cancer type across all databases. -
Adult Participation in Cancer Trials Higher Than Previously Thought
Enrollment rates varied widely by study type and institution. -
Microaggressions and Lack of Tailored Resources: Challenges for LGBTQ+ Patients With Cancer
Survey responses revealed a lack of culturally competent care and tailored resources.
More Features
First-Line Immunotherapy Continues to Best Chemo in Malignant Pleural Mesothelioma
Data suggest nivolumab plus ipilimumab provides a long-term survival benefit in patients with unresectable malignant pleural mesothelioma.
How to Prevent a Cyberattack from Derailing Cancer Care
Cyberattacks on health care organizations may not be fully preventable, but there are ways to limit their impact on cancer care.
Medical Billing Outsourcing Is on the Rise
Contracting with outside firms to handle medical billing can be a smart financial move for some medical practices.
Children With Cancer Have Greater Risk of Severe COVID-19 Outcomes
About 20% of pediatric cancer patients who developed COVID-19 had severe or critical disease.
Improving Black Representation in Oncology: ‘Be the Change’
Only 3% of medical oncologists in the United States are Black.
- Loading...
Loading...
Loading... 
Loading...